DE2937489C2 - - Google Patents

Info

Publication number
DE2937489C2
DE2937489C2 DE2937489A DE2937489A DE2937489C2 DE 2937489 C2 DE2937489 C2 DE 2937489C2 DE 2937489 A DE2937489 A DE 2937489A DE 2937489 A DE2937489 A DE 2937489A DE 2937489 C2 DE2937489 C2 DE 2937489C2
Authority
DE
Germany
Prior art keywords
bladder
compound
effect
atropine
side effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE2937489A
Other languages
German (de)
English (en)
Other versions
DE2937489A1 (de
Inventor
Geb. Richter Gertrud Dipl.-Biol. Dr.Rer.Nat. Ddr 8051 Dresden Dd Schubert
Christian Dipl.-Chem. Ddr 8053 Dresden Dd Starke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APOGEPHA ARZNEIMITTEL GMBH, O-8019 DRESDEN, DE
Original Assignee
VEB SAECHSISCHES SERUMWERK DRESDEN DDR 8010 DRESDEN DD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VEB SAECHSISCHES SERUMWERK DRESDEN DDR 8010 DRESDEN DD filed Critical VEB SAECHSISCHES SERUMWERK DRESDEN DDR 8010 DRESDEN DD
Publication of DE2937489A1 publication Critical patent/DE2937489A1/de
Application granted granted Critical
Publication of DE2937489C2 publication Critical patent/DE2937489C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
DE19792937489 1978-10-09 1979-09-17 Arzneimittel zur behandlung hypertoner funktionszustaende der harnblase Granted DE2937489A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD78208336A DD139212A1 (de) 1978-10-09 1978-10-09 Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten

Publications (2)

Publication Number Publication Date
DE2937489A1 DE2937489A1 (de) 1980-04-17
DE2937489C2 true DE2937489C2 (fr) 1990-08-02

Family

ID=5514770

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19792937489 Granted DE2937489A1 (de) 1978-10-09 1979-09-17 Arzneimittel zur behandlung hypertoner funktionszustaende der harnblase

Country Status (5)

Country Link
JP (1) JPS5555117A (fr)
CH (1) CH644016A5 (fr)
DD (1) DD139212A1 (fr)
DE (1) DE2937489A1 (fr)
GB (1) GB2031727B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10129832A1 (de) * 2001-06-17 2003-07-10 Berolina Drug Dev Ab Svedala Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel
RU2585759C2 (ru) * 2012-01-30 2016-06-10 Тайхо Фармасьютикал Ко., Лтд. Новый эфир уксусной кислоты или его соль

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3742580C1 (de) * 1987-12-16 1989-05-11 Schaper & Bruemmer Gmbh Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
US7851633B2 (en) * 2006-06-09 2010-12-14 Beiersdorf Ag Piperidinium compounds and cosmetic compositions containing them
JP5908072B2 (ja) 2012-05-15 2016-04-26 大鵬薬品工業株式会社 腹圧性尿失禁予防剤及び／又は治療剤
EP3006427B1 (fr) * 2013-05-30 2017-11-15 Taiho Pharmaceutical Co., Ltd. Compose d'ester d'acide benzilique fluore et son sel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10129832A1 (de) * 2001-06-17 2003-07-10 Berolina Drug Dev Ab Svedala Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel
RU2585759C2 (ru) * 2012-01-30 2016-06-10 Тайхо Фармасьютикал Ко., Лтд. Новый эфир уксусной кислоты или его соль

Also Published As

Publication number Publication date
DE2937489A1 (de) 1980-04-17
CH644016A5 (de) 1984-07-13
JPS5555117A (en) 1980-04-22
JPS6251242B2 (fr) 1987-10-29
GB2031727B (en) 1982-11-03
GB2031727A (en) 1980-04-30
DD139212A1 (de) 1979-12-19

Similar Documents

Publication Publication Date Title
DE60009346T2 (de) Buprenorphin enthaltende analgetische zusammensetzungen
DE69720985T2 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
DE69735552T2 (de) Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz
DE69529156T2 (de) Verwendung von amino-hydrierten chinazolinverbindungen und ihren derivaten zur entwöhnung bei drogenabhängigkeit
WO1994006423A1 (fr) Nouvelle utilisation d'inhibiteurs de la phosphodiesterase iv
DE68913907T2 (de) Methode zur Behandlung des interstitiellen Blasenentzündung.
AT389226B (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
DE2937489C2 (fr)
DE60026491T2 (de) Melagatran zur behandlung von entzündungen
DE3317692A1 (de) Verwendung von metkephamid oder eines pharmazeutisch unbedenklichen salzes hiervon als analgetikum bei traechtigen weiblichen tieren und insbesondere bei schwangeren frauen
DE69908645T2 (de) Kombinationen von cholesteryl ester transfer protein inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
DE2759171A1 (de) Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
DE2520978B2 (de) Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
DE69132782T2 (de) Verwendung von angiotensin-ii-antagonisten in der behandlung der linken ventrikulären hypertrophie
EP1397128B1 (fr) Agoniste opiace de type kappa pour le traitement de la vessie irritable
EP1152762A1 (fr) Utilisation de desoxypeganine dans le traitement de la demence d'alzheimer
DE69125204T2 (de) Therapeutische Anwendung von Histamin-H3-Agonisten, neue Wirkstoffe und Verwendung zur Herstellung von Arzneimitteln
DE2708520C2 (fr)
DE68907976T2 (de) Verwendung eines Thromboxan-A2-Rezeptorantagonist zur Herstellung eines Arzeneimittels zur Behandlung pulmonarer Hypertonie, die durch Protamin-induzierte Neutralisation von Heparin verursacht wird.
EP0132595B1 (fr) Agent tocolytique
WO2000032199A1 (fr) Utilisation de galanthamine et de derives de galanthamine en cas de lesions cerebrales fonctionnelles aigues
DE2720194A1 (de) Verwendung von trazodon und etoperidon zum behandeln des parkinson-tremors und anderer extra- pyramidaler syndrome
DE4205843C2 (de) Verwendung des alpha, alpha-Diphenylessigsäure-4-(N-methyl-piperidyl)-esters zur Beeinflussung des Harnblasentonus
EP0995441B1 (fr) Combination des médicaments pour la therapie des dysfonctionnements erectiles
DE2502684C2 (fr)

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: VEB SAECHSISCHES SERUMWERK DRESDEN, DDR 8012 DRESD

8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: APOGEPHA ARZNEIMITTEL GMBH, O-8019 DRESDEN, DE

8381 Inventor (new situation)

Free format text: SCHUBERT, GEB. RICHTER, GERTRUD, DIPL.-BIOL. DR.RER.NAT., O-8051 DRESDEN, DE STARKE, CHRISTIAN, DIPL.-CHEM., O-8053 DRESDEN, DE PEIN, ECKHARDT, DR., 3410 NORTHEIM, DE

V448 Application of spc

Free format text: PRODUCT NAME: PROPIVERINHYDROCHLORID; REGISTRATION NO/DATE: NICHT BEKANNT, 19981021

Spc suppl protection certif: 198 75 042

Filing date: 19981021

V448 Application of spc

Free format text: PRODUCT NAME: PROPIVERINHYDROCHLORID; REGISTRATION NO/DATE: 44279.00.00, 19981221

Spc suppl protection certif: 199 75 038

Filing date: 19990515

V457 Spc granted

Free format text: PRODUCT NAME: PROPIVERINHYDROCHLORID; REGISTRATION NO/DATE: 44279.00.00, 19981221

Spc suppl protection certif: 199 75 038

Filing date: 19990515

V454 Spc application withdrawn or to be regarded as withdrawn

Free format text: PRODUCT NAME: PROPIVERINHYDROCHLORID; REGISTRATION NO/DATE: NICHT BEKANNT, 19981021

Spc suppl protection certif: 198 75 042

Filing date: 19981021

V464 Spc expired

Free format text: PRODUCT NAME: PROPIVERINHYDROCHLORID; REGISTRATION NO/DATE: 44279.00.00, 19981221

Spc suppl protection certif: 199 75 038

Filing date: 19990515